NEWS and OPINIONS
FDA Greenlights Twice-A-Year HIV Prevention Drug
By Antonio Pequeño IV - Forbes - Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir) will become...
Stem cell platform aims to recreate brain’s immune system using lab-grown human microglia cells
by Harvard University - Microglia are a specialized type of immune cell that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that...
Research Spotlight: Preventing stalling to improve CAR-T cells’ efficacy against tumors
By Mass General Brigham - Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass General Cancer Center, is senior author and Stefanie Bailey, PhD, Hana Takei, and Giulia Escobar, PhD of the Krantz...
Son’s diabetes diagnosis sent scientist on quest for cure
by Kermit Pattison - The Harvard Gazette - Decades later, Doug Melton and team are testing treatment that could make insulin shots obsolete. Doug Melton’s life irrevocably changed the day his child was diagnosed with a life-threatening disease. But unlike most other...
Blocking a single enzyme rewires limb regrowth in axolotls
By Vijay Kumar Malesu - Medical life Sciences News - In a recent study published in the journal Nature Communications, researchers in the United States explored how cytochrome P450 family 26 subfamily B member 1 (CYP26B1)-mediated retinoic acid (RA) breakdown...
Dozens of states sue to block the sale of 23andMe personal genetic data
By The Associated Press - PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology...
Stem cell therapies advance in Parkinson’s disease and beyond
By Natalie Healey - Nature Medicine - Landmark trials using stem cells to treat Parkinson’s disease in the USA and Japan mark a turning point for cell therapy in neurodegeneration. Similar approaches to Alzheimer’s disease and amyotrophic lateral sclerosis are also...
No More Transplants? New Gene Therapy Targets Blood Stem Cells Directly
By Fondazione Telethon - SciTechDaily - Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing the development of potential treatments for genetic disorders. A team of scientists from the San...
How our bones are repaired by skeletal stem cells: Scientist discover four major subtypes
by Sarah Williams, Stanford University - MedicalXpress - Whether you are a competitive athlete or an older adult, strong bones are essential—not only for movement, but also for overall health. Now, a new study has shed new light on how our bones are maintained and...
After groundbreaking CRISPR therapy, a homecoming
By Meghana Keshavan - Stat News - From my colleague Jason Mast: KJ Muldoon, the first infant treated with a personalized gene-editing drug, has been discharged from the hospital for the first time in his life, the Children’s Hospital of Philadelphia announced Tuesday....
Natural molecule reverses age- and dementia-related cognitive decline
By Paul McClure - News Atlas - In a new study, researchers identified a molecule produced by a particular type of brain cell that reversed the cognitive decline seen in both healthy aging and dementia. It provides a deeper understanding of the aging process and a...
CAR T-Cell Therapy: New Advances Move On Past Setbacks
By Tiffany Yesavag - Genetic Bioengineering & Biotechnology News - Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked significant...